Literature DB >> 12746236

Alteration of the purinergic modulation of enteric neurotransmission in the mouse ileum during chronic intestinal inflammation.

Joris G De Man1, Tom C Seerden, Benedicte Y De Winter, Eric A Van Marck, Arnold G Herman, Paul A Pelckmans.   

Abstract

1. The effect of chronic intestinal inflammation on the purinergic modulation of cholinergic neurotransmission was studied in the mouse ileum. Chronic intestinal inflammation was induced by infection of mice with the parasite Schistosoma mansoni during 16 weeks. 2. S. mansoni infection induced a chronic inflammatory response in the small intestine, which was characterised by intestinal granuloma formation, increased intestinal wall thickness, blunted mucosal villi and an enhanced activity of myeloperoxidase. 3. In control ileum and in chronically inflamed ileum, electrical field stimulation (EFS) of longitudinal muscle strips induced frequency-dependent contractions that were abolished by tetrodotoxin (TTX) and atropine. Carbachol induced dose-dependent contractions that were not affected by TTX but abolished by atropine. 4. In control ileum, adenosine and ATP dose-dependently inhibited the contractions to EFS. Theophylline and 8-phenyltheophylline, P(1) and A(1) receptor antagonists respectively, prevented this inhibitory effect of adenosine and ATP. PPADS, DMPX and MRS 1220, antagonists of P(2), A(2) and A(3) receptors, respectively, did not prevent this inhibitory effect of adenosine and ATP. Adenosine and ATP did not affect the contractions to carbachol. 5. The inhibitory effect of adenosine and ATP on contractions to EFS in control ileum was mimicked by the stable adenosine analogue methyladenosine and by the A(1)-receptor agonist N(6)-cyclohexyladenosine, but not by the A3 receptor agonist 2-Cl IB-MECA or by the ATP analogues alphabeta-methylene-ATP and ADPbetaS. The inhibitory effect of adenosine on contractions to EFS was lost after prolonged (90 min) treatment of control ileum with methyladenosine (100 micro M). 6. In chronically inflamed ileum, adenosine, methyladenosine, N(6)-cyclohexyladenosine and ATP all failed to inhibit the cholinergic nerve-mediated contractions to EFS. Also theophylline, 8-phenyltheophylline, PPADS, DMPX and MRS 1220 had no effect on the contractions to EFS and carbachol. The loss of effect of adenosine and ATP was still evident after 52 weeks of infection. 7. These results indicate that in physiological conditions neuronal adenosine A(1) receptors modulate cholinergic nerve activity in the mouse ileum. However, during chronic intestinal inflammation, this purinergic modulation of cholinergic nerve activity is impaired. This suggests that chronic intestinal inflammation leads to a dysfunction of specific neuronal regulatory mechanisms in the enteric nervous system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746236      PMCID: PMC1573820          DOI: 10.1038/sj.bjp.0705218

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.

Authors:  A Ohta; M Sitkovsky
Journal:  Nature       Date:  2001 Dec 20-27       Impact factor: 49.962

Review 2.  Schistosomiasis.

Authors:  Allen G P Ross; Paul B Bartley; Adrian C Sleigh; G Richard Olds; Yuesheng Li; Gail M Williams; Donald P McManus
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

3.  Inosine reduces inflammation and improves survival in a murine model of colitis.

Authors:  J G Mabley; P Pacher; L Liaudet; F G Soriano; G Haskó; A Marton; C Szabo; A L Salzman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-08-28       Impact factor: 4.052

4.  Disturbance of the prejunctional modulation of cholinergic neurotransmission during chronic granulomatous inflammation of the mouse ileum.

Authors:  J G De Man; T G Moreels; B Y De Winter; J J Bogers; E A Van Marck; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

5.  Activation of presynaptic A1-receptors by endogenous adenosine inhibits acetylcholine release in the guinea-pig ileum.

Authors:  J J Lee; C Talubmook; M E Parsons
Journal:  J Auton Pharmacol       Date:  2001-02

6.  Generalized loss of inhibitory innervation reverses serotonergic inhibition into excitation in a rabbit model of TNBS-colitis.

Authors:  Inge Depoortere; Theo Thijs; Theo L Peeters
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

7.  Colitis-induced alterations in adrenergic control of circular smooth muscle in vitro in rats.

Authors:  A Zhao; C Bossone; V Piñeiro-Carrero; T Shea-Donohue
Journal:  J Pharmacol Exp Ther       Date:  2001-11       Impact factor: 4.030

8.  Neuronal nitric oxide synthase activity is increased during granulomatous inflammation in the colon and caecum of pigs infected with Schistosoma japonicum.

Authors:  O B Balemba; K Mortensen; W D Semuguruka; A Hay-Schmidt; M V Johansen; V Dantzer
Journal:  Auton Neurosci       Date:  2002-07-31       Impact factor: 3.145

9.  Temporal distribution of distinct mast cell phenotypes during intestinal schistosomiasis in mice.

Authors:  Frederik De Jonge; Luc Van Nassauw; Frans Van Meir; Hugh R P Miller; Eric Van Marck; Jean-Pierre Timmermans
Journal:  Parasite Immunol       Date:  2002-05       Impact factor: 2.280

Review 10.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Authors:  B B Fredholm; A P IJzerman; K A Jacobson; K N Klotz; J Linden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 18.923

View more
  21 in total

Review 1.  P2X ion channel receptors and inflammation.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2016-01-06       Impact factor: 3.765

2.  New bioinformatics approach to analyze gene expressions and signaling pathways reveals unique purine gene dysregulation profiles that distinguish between CD and UC.

Authors:  Leszek Rybaczyk; Andrew Rozmiarek; Kristin Circle; Iveta Grants; Bradley Needleman; Jacqueline E Wunderlich; Kun Huang; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

Review 3.  Potential for developing purinergic drugs for gastrointestinal diseases.

Authors:  Fernando Ochoa-Cortes; Andromeda Liñán-Rico; Kenneth A Jacobson; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

4.  Differential role of tachykinin NK3 receptors on cholinergic excitatory neurotransmission in the mouse stomach and small intestine.

Authors:  J G De Man; B Y De Winter; H U De Schepper; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

5.  Purinergic mechanisms in the control of gastrointestinal motility.

Authors:  J C Bornstein
Journal:  Purinergic Signal       Date:  2007-10-06       Impact factor: 3.765

6.  Adenosine negatively regulates duodenal motility in mice: role of A(1) and A(2A) receptors.

Authors:  M G Zizzo; M Mastropaolo; L Lentini; F Mulè; R Serio
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

7.  Impact of disrupting adenosine A₃ receptors (A₃⁻/⁻ AR) on colonic motility or progression of colitis in the mouse.

Authors:  Tianhua Ren; Iveta Grants; Mazin Alhaj; Matt McKiernan; Marlene Jacobson; Hamdy H Hassanain; Wendy Frankel; Jacqueline Wunderlich; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2010-12-03       Impact factor: 5.325

8.  A holistic view of adenosine in the control of intestinal neuromuscular functions: the enteric 'purinome' concept.

Authors:  Luca Antonioli; Matteo Fornai; Rocchina Colucci; Marco Tuccori; Corrado Blandizzi
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

9.  Neuronal activation and plasticity in Schistosoma mansoni infected mice.

Authors:  Faiza B Abdu
Journal:  Saudi J Biol Sci       Date:  2012-07-22       Impact factor: 4.219

10.  Dual effects of adenosine on acetylcholine release from myenteric motoneurons are mediated by junctional facilitatory A(2A) and extrajunctional inhibitory A(1) receptors.

Authors:  Margarida Duarte-Araújo; Carlos Nascimento; M Alexandrina Timóteo; Teresa Magalhães-Cardoso; Paulo Correia-de-Sá
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.